MAPK3 and obesity disorder: Hepatic ERK1/2 activities have been found to be increased in both genetic and diet‐induced obesity mouse models,143 triggering overall IR and impaired glucose homeostasis, while obese mice with decreased hepatic ERK1/2 showed better systemic insulin and glucose tolerance.